Excellere Capital Fund III, L.P. Announces Continuation of Commitment Period Following Overwhelmingly Affirmative Vote from Limited Partners

Denver, Co March 30, 2020 – Excellere Partners is pleased to announce the continuation of the commitment period and investment activities of Excellere Capital Fund III, L.P. (the “Fund”) following a vote of all the limited partner interests in the Fund. The Fund entered into an interim period following the death of David Kessenich on January 22, 2020. The interim period would have lapsed and the commitment period continued on May 21, 2020 absent a vote by the limited partners to suspend; however, the limited partners of the fund voted to resume the commitment period early on March 24, 2020.

“We are appreciative and honored by the strong support our limited partners have provided by the early and overwhelmingly affirmative vote to allow the Fund to continue its investment activities,” said Brad Cornell, Ryan Glaws, Matt Hicks and Patrick O’Keefe, Managing Partners of Excellere. “This is a testament to the strength of our entire team and our steadfast focus on deploying a multi-faceted origination strategy, disciplined underwriting program and proprietary value creation process alongside our entrepreneur and management partners.”

The Fund currently has investments in AIS Healthcare, Biocare Medical, Concord Technologies, SePRO, and ParcelShield, which entered into a partnership with Excellere on March 2, 2020.

About Excellere Partners
Excellere Partners is a Denver-based private equity firm with $1.36 billion of committed capital across Fund I, Fund II and Fund III, specializing in partnering with entrepreneurs and management teams to build industry leaders. The firm employs a proven research-driven, top down investment strategy, and supports its entrepreneurs and management teams with a proprietary value creation process designed to enhance corporate and operational infrastructure to enable scalability and rapid growth. Excellere’s investments are focused on differentiated and growth-oriented companies positioned to benefit from industry consolidation and favorable macro-economic and demographic trends. The Firm’s targeted industry sectors include healthcare; industrial technology and services; and business services. For more information about Excellere, please visit

« Back to News